Literature DB >> 27943613

Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells.

Gabriela Odent Grigorescu1, Ana-Maria Rosca1, Mihai Bogdan Preda1, Raluca Tutuianu1, Maya Simionescu1, Alexandrina Burlacu1.   

Abstract

Here we investigated the impact of hypoxic environment on the angiogenic properties of early-outgrowth endothelial progenitor cells (EPCs), with particular focus on the role of secreted vascular endothelial growth factor-A (VEGF-A) and stromal derived factor-1 (SDF-1) in mediating these effects. We found that cultured EPCs secreted factors with paracrine effects on chemotaxis, migration, proliferation and tube formation of mature endothelial cells (ECs), and these properties were not affected by hypoxia. Depletion of VEGF-A did not change the ability of EPC-conditioned medium (CM) to promote EC migration and tube formation in vitro, suggesting that the pro-angiogenic paracrine effects of EPCs did not totally rely on the presence of VEGF-A. These findings were confirmed by in vivo experiments, on a mouse model of hind limb ischaemia, which showed that VEGF-depleted EPC-CM sustained tissue perfusion at the same level as complete EPC-CM. However, concomitant deletion of VEGF-A and SDF-1 in EPC-CM impaired the pro-angiogenic properties of EPC-CM, by inhibition of EC spreading in culture, tube-like structure formation on Matrigel support, in vivo neovessels formation and ischaemic hind limb regeneration. Taken together, our data demonstrate that: (i) hypoxia does not affect the capacity of EPCs to support the angiogenic process; (ii) the absence of either VEGF-A or SDF-1 from EPC-CM can be rescued by the presence of the other one, so that the overall angiogenic effects remain unchanged; and (iii) and the concomitant deletion of VEGF-A and SDF-1 from EPC-CM impairs its pro-angiogenic effect, both in vitro and in vivo.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  SDF-1; VEGF-A; angiogenesis; endothelial progenitor cells; hypoxia; paracrine

Mesh:

Substances:

Year:  2016        PMID: 27943613     DOI: 10.1002/term.2233

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  14 in total

1.  Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.

Authors:  Matthias Kolibabka; Nadine Dietrich; Thomas Klein; Hans-Peter Hammes
Journal:  Diabetologia       Date:  2018-08-10       Impact factor: 10.122

2.  Nicotinamide Riboside Enhances Endothelial Precursor Cell Function to Promote Refractory Wound Healing Through Mediating the Sirt1/AMPK Pathway.

Authors:  Zhen-Hua Wang; Xiao-Gang Bao; Jun-Jie Hu; Si-Bo Shen; Guo-Hua Xu; Ye-Lin Wu
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

Review 3.  The role of tumor microenvironment in resistance to anti-angiogenic therapy.

Authors:  Shaolin Ma; Sunila Pradeep; Wei Hu; Dikai Zhang; Robert Coleman; Anil Sood
Journal:  F1000Res       Date:  2018-03-15

4.  CXCR-4 expression by circulating endothelial progenitor cells and SDF-1 serum levels are elevated in septic patients.

Authors:  Christian Patry; Daniela Stamm; Christian Betzen; Burkhard Tönshoff; Benito A Yard; Grietje Ch Beck; Neysan Rafat
Journal:  J Inflamm (Lond)       Date:  2018-05-16       Impact factor: 4.981

5.  Downregulation of miRNA‑328 promotes the angiogenesis of HUVECs by regulating the PIM1 and AKT/mTOR signaling pathway under high glucose and low serum condition.

Authors:  Yan Zou; Fei Wu; Qi Liu; Xian Deng; Rui Hai; Xuemei He; Xiangyu Zhou
Journal:  Mol Med Rep       Date:  2020-05-12       Impact factor: 2.952

6.  Combined Transplantation of Adipose Tissue-Derived Stem Cells and Endothelial Progenitor Cells Improve Diabetic Erectile Dysfunction in a Rat Model.

Authors:  Qiyun Yang; Wanmei Chen; Chi Zhang; Yun Xie; Yong Gao; Cuncan Deng; Xiangzhou Sun; Guihua Liu; Chunhua Deng
Journal:  Stem Cells Int       Date:  2020-07-03       Impact factor: 5.443

7.  Identification of inflammatory and vascular markers associated with mild cognitive impairment.

Authors:  Xue-Ning Shen; Yanxia Lu; Crystal Tze Ying Tan; Ling-Yun Liu; Jin-Tai Yu; Lei Feng; Anis Larbi
Journal:  Aging (Albany NY)       Date:  2019-04-30       Impact factor: 5.682

8.  Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on Vascular Degeneration in Oxygen-Induced Retinopathy.

Authors:  Michel Desjarlais; Pakiza Ruknudin; Maëlle Wirth; Isabelle Lahaie; Rabah Dabouz; José Carlos Rivera; Tiffany Habelrih; Samy Omri; Pierre Hardy; Alain Rivard; Sylvain Chemtob
Journal:  Front Cell Dev Biol       Date:  2021-05-28

9.  Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model.

Authors:  Yi Huang; Jie Gao; Yiduo Zhou; Shuo Wu; Yunpeng Shao; Haoliang Xue; Baixin Shen; Liucheng Ding; Zhongqing Wei
Journal:  Stem Cell Res Ther       Date:  2020-07-10       Impact factor: 6.832

10.  Low-Energy Shockwave Treatment Promotes Endothelial Progenitor Cell Homing to the Stenotic Pig Kidney.

Authors:  Yu Zhao; Adrian Santelli; Xiang-Yang Zhu; Xin Zhang; John R Woollard; Xiao-Jun Chen; Kyra L Jordan; James Krier; Hui Tang; Ishran Saadiq; Amir Lerman; Lilach O Lerman
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.